CME Group Inc.'s Stock Analysis

CME Group Reports Record Annual Revenue and Earnings for 2025

CME Group Inc. announced its financial results for the fourth quarter and full year of 2025, reporting record annual revenue of $6.5 billion, a 6% increase from the previous year. The company achieved an operating income of $4.2 billion and net income of $4.1 billion, with diluted earnings per share at $11.16 for the year. In the fourth quarter alone, revenue reached $1.6 billion, with an operating income of $1.0 billion and net income of $1.2 billion, translating to diluted earnings per share of $3.24. The company also highlighted a significant increase in average daily volume, reaching 28.1 million contracts, driven by growth in commodities and financial trading.

CME Group's market data revenue for the year was reported at $803 million, marking a 13% increase. The company maintained a strong cash position with approximately $4.6 billion in cash and $3.4 billion in debt as of December 31, 2025. CME Group returned nearly $30 billion to shareholders through dividends since 2012, with approximately $3.9 billion paid out in 2025. The company continues to focus on enhancing trading efficiencies and expanding its product offerings, including new initiatives in U.S. Treasury clearing and cryptocurrency trading.

Feb 04, 2026 07:06:41

CME Group Announces Pricing Changes to Clients

On February 2, 2026, CME Group Inc. informed its clients about new pricing changes through Special Executive Report 9676. This notice has been made available on the company's website for client access.

The report clarifies that the information provided is not considered 'filed' under the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as formal filings. Additionally, the report includes a cover page from CME Group's Current Report on Form 8-K, formatted in Inline XBRL, and has been duly signed by authorized representatives of the company.

Feb 02, 2026 09:31:15

CME Group Reports Third-Quarter 2025 Financial Results

CME Group Inc. reported financial results for the third quarter of 2025, with total revenue of $1.5 billion and operating income of $973 million. The company's net income was $908 million, translating to diluted earnings per share of $2.49. On an adjusted basis, net income increased to $1.0 billion, with adjusted earnings per share of $2.68. The report highlighted a strong demand for CME Group's markets across various asset classes, leading to significant revenue from clearing and transaction fees, totaling $1.2 billion, and record market data revenue of $203 million.

As of September 30, 2025, CME Group had $2.6 billion in cash and $3.4 billion in debt. The company has returned over $29.5 billion to shareholders through dividends since 2012, with approximately $3.5 billion paid in the first nine months of the year. CME Group continues to focus on improving efficiencies and expanding its product offerings, including a new partnership with FanDuel and enhanced trading options in cryptocurrency futures and options.

Oct 22, 2025 07:05:05

CME Group Chief Accounting Officer Announces Retirement Plans

Jack Tobin, the Managing Director and Chief Accounting Officer of CME Group Inc., has announced his decision to retire, effective October 30, 2026. He has been with the company for over 23 years and has served as Chief Accounting Officer since 2015. His retirement is voluntary and not related to any disagreements regarding the company's practices.

The company will begin searching for a successor to ensure a smooth transition of responsibilities. Mr. Tobin will assist in this process, working with the new appointee to facilitate the handover of his duties.

Sep 11, 2025 12:06:44

CME Group Wins Jury Verdict in Class Action Lawsuit

On July 25, 2025, a jury delivered a unanimous verdict in favor of CME Group Inc. and the Board of Trade of the City of Chicago, Inc. in a class action lawsuit initiated on January 15, 2014. The lawsuit involved claims from certain Class B shareholders of CME Group and Class B members of CBOT, who alleged breaches of contract and the implied covenant of good faith and fair dealing regarding their rights as outlined in the defendants’ Certificates of Incorporation.

The verdict concluded the legal dispute in favor of CME Group and CBOT, potentially impacting shareholder confidence and the company's legal standing. This outcome may influence investor perceptions and stock performance in the future.

Jul 25, 2025 16:19:56

CME Group Reports Record Revenue and Earnings for Q2 2025

CME Group Inc. reported record financial results for the second quarter of 2025, achieving revenue of $1.7 billion, which is a 10% increase from the same period in 2024. The company also reported an operating income of $1.1 billion and a net income of $1.0 billion, translating to diluted earnings per share of $2.81. Adjusted figures showed net income of $1.1 billion and adjusted earnings per share of $2.96. The average daily volume of contracts traded reached 30.2 million, marking a 16% rise year-over-year.

The company's clearing and transaction fees revenue amounted to $1.4 billion, with the average rate per contract at $0.690. CME Group held $2.2 billion in cash and had $3.4 billion in debt as of June 30, 2025. Over the first half of the year, the company paid approximately $3.0 billion in dividends and has returned a total of $29.1 billion to shareholders since implementing its variable dividend policy in 2012. The growth in new retail traders was notable, increasing by 57% year-over-year, indicating broader market engagement with CME Group's offerings.

Jul 23, 2025 07:08:45

CME Group Reports Record Revenue and Earnings for Q1 2025

CME Group Inc. announced record financial results for the first quarter of 2025, reporting revenue of $1.6 billion, a 10% increase from the same period in 2024. The company also achieved a record average daily volume of 29.8 million contracts, with notable growth across all asset classes. Adjusted net income reached $1.0 billion, with diluted earnings per share at $2.80, reflecting strong demand for their markets amid economic uncertainty.

As of March 31, 2025, CME Group held $1.6 billion in cash and had $3.4 billion in debt. The company paid approximately $2.6 billion in dividends during the first quarter, contributing to a total of $28.6 billion returned to shareholders since 2012. CME Group will hold a Q&A conference call to discuss these results further.

Apr 23, 2025 07:07:16

S&P Global and CME Group Sell OSTTRA for $3.1 Billion

S&P Global and CME Group have announced a definitive agreement to sell OSTTRA, a provider of post-trade solutions, to KKR for a total enterprise value of $3.1 billion. This sale will be divided evenly between the two companies, who formed OSTTRA as a joint venture in 2021. The management team of OSTTRA will remain in place, and KKR plans to support the company's growth by investing in technology and innovation, aiming to enhance its services to customers in the global financial ecosystem. The transaction is expected to close in the second half of 2025, pending regulatory approvals.

While the announcement highlights the growth and market position of OSTTRA, it also reflects a strategic shift for S&P Global and CME Group as they optimize their portfolios. The transaction is part of S&P Global's ongoing strategy to fuel future growth. KKR's investment approach includes creating an equity ownership program for OSTTRA employees, which is intended to engage the workforce in the company's success. Further financial details were not disclosed, and the transaction is subject to customary closing conditions.

Apr 14, 2025 08:35:43

CME Group Reports $6.1 Billion Revenue for Full-Year 2024

CME Group Inc. achieved record financial results for the full year 2024, reporting total revenue of $6.1 billion, a 10% increase compared to the previous year. The company also noted record levels in adjusted operating income, adjusted net income, and adjusted earnings per share, with adjusted net income reaching $3.7 billion. Additionally, the fourth quarter saw a revenue increase of 6%, contributing to an overall strong performance across various asset classes, including interest rates and agricultural markets. The company declared dividends totaling $3.8 billion in 2024, with a notable increase in the first-quarter dividend for 2025 to $1.25 per share, reflecting a 9% rise from the prior level.

On the downside, CME Group's average daily volume (ADV) for the fourth quarter was stable at 25.5 million contracts, which was consistent with the same period in 2023, indicating no growth in trading activity. The company also reported a significant amount of debt, totaling $3.4 billion, which could be a point of concern for investors. Furthermore, the press release highlighted various risks and uncertainties that could affect future performance, including increased competition and potential regulatory changes, which may pose challenges to sustaining growth.

Feb 12, 2025 07:05:59

Company Files Financial Report with Required Signatures

The press release indicates that the company has complied with the Securities Exchange Act of 1934 by submitting its financial statements and necessary exhibits. This adherence to regulatory requirements reflects the company's commitment to transparency in its financial reporting.

However, the release does not provide specific financial results or metrics that would give insights into the company's performance. The lack of detailed financial information may leave stakeholders seeking more clarity on the company's current financial health.

Dec 11, 2024 09:16:01